Pharmamarketeer

Researchers identify new drug candidates for treating patients with severe COVID-19

COVID-19

University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2–the virus that causes COVID-19 – and then used an FDA-approved cancer drug to blunt the viral protein’s detrimental effects.

Medhc-fases-banner
Advertentie(s)